Hostname: page-component-cd9895bd7-hc48f Total loading time: 0 Render date: 2024-12-23T15:23:16.168Z Has data issue: false hasContentIssue false
  • English
  • Français

The Need for Vigilance in Identifying Those at Risk from Drug-induced Headache

Published online by Cambridge University Press:  06 October 2014

Michael Kennedy  and
Judith Kennedy
Judith Kennedy
Affiliation:
St Vincent's Hospital, Sydney
Get access

Abstract

An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Commentaries
Information
Behaviour Change , Volume 15 , Issue 3 , September 1998 , pp. 194 - 195
Copyright
Copyright © The Authors 1998

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Eadie, M.J. (1997). Neurological diseases. In Speightt, T.M. & Holford, N.H.G. (Eds.), Avery's drug treatment (pp. 1347–1397). New Zealand: Adis International.Google Scholar
Forsyth, M.R., & Martin, P.R., (1997). The need for vigilance. Behaviour Change, 14, 227–229.Google Scholar
New South Wales Government Poisons Act, 1996, Regulation Part 4 “Drugs of Addiction (S8)”, Gazette Number 108, 28 08 1994.Google Scholar
Public notice. (1997, 12). Medicare Forum, 8(4).Google Scholar
Somygi, A.A. (1997). Pethidine is inappropriate for migraine. Australian Prescriber, 20(3), 71.Google Scholar